Amendment to Stock OptionAmendment to Stock Option • July 26th, 2013 • Five Prime Therapeutics Inc • Pharmaceutical preparations
Contract Type FiledJuly 26th, 2013 Company IndustryThis Amendment to Stock Option (this “Amendment”) is entered into between Five Prime Therapeutics, Inc., a Delaware corporation (the “Company”), and Aron Knickerbocker, effective as of March 15, 2011 (the “Amendment Effective Date”). Each capitalized term used but not defined in this Amendment has the meaning assigned to such term in the Option (as defined below).